Ernexa Therapeutics Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Ernexa Therapeutics Inc. (ERNA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 868 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 868.00 shares, a 6576.92% increase year-over-year.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 863.34K shares, a 6365.01% increase year-over-year.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 13.00 shares, a 100.00% decline year-over-year.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.35K shares, a 99.96% decline year-over-year.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 363.00K shares, a 73.68% increase from fiscal 2024.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 209.00K shares, a 99.23% decline from fiscal 2023.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 27.21M shares, a 435.25% increase from fiscal 2022.
- Ernexa Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.08M shares, a 2286.38% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 868.00 shares 10-Q · filed 2026-08-06 | 890.00 shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 863.34K shares 10-Q · filed 2026-05-11 | |||||||
| 2025-12-31 | 363.00K shares 10-K · filed 2026-03-13 | |||||||
| 2025-09-30 | 342.00K shares 10-Q · filed 2025-11-07 | |||||||
| 2025-06-30 | 13.00 shares 10-Q · filed 2026-08-06 | 13.00 shares 10-Q · filed 2026-08-06 | 330.00K shares 10-Q · filed 2025-08-13 | |||||
| 2025-03-31 | 13.35K shares 10-Q · filed 2026-05-11 | 5.01M shares 10-Q · filed 2025-05-07 | ||||||
| 2024-12-31 | 209.00K shares 10-K · filed 2026-03-13 | 3.14M shares 10-K · filed 2025-03-12 | ||||||
| 2024-09-30 | 39.04M shares 10-Q · filed 2024-11-12 | 2.08M shares 10-Q · filed 2025-11-07 | 39.04M shares 10-Q · filed 2024-11-12 | |||||
| 2024-06-30 | 31.08M shares 10-Q · filed 2024-08-13 | 2.07M shares 10-Q · filed 2025-08-13 | 31.08M shares 10-Q · filed 2024-08-13 | |||||
| 2024-03-31 | 30.44M shares 10-Q · filed 2025-05-07 | |||||||
| 2023-12-31 | 27.21M shares 10-K · filed 2025-03-12 | |||||||
| 2023-09-30 | 14.42M shares 10-Q · filed 2024-11-12 | 14.42M shares 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | 5.24M shares 10-Q · filed 2024-08-13 | 5.24M shares 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | 5.28M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 5.08M shares 10-K · filed 2024-03-14 | |||||||
| 2022-09-30 | 722.00K shares 10-Q · filed 2023-11-13 | 722.00K shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 563.00K shares 10-Q · filed 2023-08-11 | 11.24M shares 10-Q · filed 2022-08-11 | 563.00K shares 10-Q · filed 2023-08-11 | 11.24M shares 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | 670.00K shares 10-Q · filed 2023-05-11 | 13.41M shares 10-Q · filed 2022-07-01 | ||||||
| 2021-12-31 | 213.00K shares 10-K · filed 2023-03-20 | 4.27M shares 10-K · filed 2022-04-15 | ||||||
| 2021-09-30 | 193.00K shares 10-Q · filed 2022-11-14 | 193.00K shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 3.51M shares 10-Q · filed 2022-08-11 | 3.51M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 42.00K shares 10-Q · filed 2022-07-01 | |||||||
| 2020-12-31 | 0.00 shares 10-K/A · filed 2022-07-01 | 210.00K shares 10-K · filed 2021-03-11 | ||||||
| 2020-09-30 | 239.00K shares 10-Q · filed 2020-11-13 | 167.00K shares 10-Q · filed 2020-11-13 | ||||||
| 2020-06-30 | 169.00K shares 10-Q · filed 2020-08-07 | 169.00K shares 10-Q · filed 2020-08-07 | ||||||
| 2020-03-31 | 172.00K shares 10-Q · filed 2020-05-20 | |||||||
| 2019-12-31 | 210.00K shares 10-K · filed 2021-03-11 | |||||||
| 2019-09-30 | 249.00K shares 10-Q · filed 2020-11-13 | 249.00K shares 10-Q · filed 2020-11-13 | ||||||
| 2019-06-30 | 247.00K shares 10-Q · filed 2020-08-07 | 247.00K shares 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | 262.00K shares 10-Q · filed 2020-05-20 | |||||||
| 2018-12-31 | 219.00K shares 10-K · filed 2020-03-19 | |||||||
| 2018-09-30 | 274.00K shares 10-Q · filed 2019-11-01 | 419.00K shares 10-Q · filed 2018-11-09 | ||||||
| 2018-06-30 | 288.00K shares 10-Q · filed 2019-08-12 | 433.00K shares 10-Q · filed 2018-08-06 | ||||||
| 2018-03-31 | 288.00K shares 10-Q · filed 2019-05-14 | 433.00K shares 10-Q · filed 2018-05-11 | ||||||
| 2017-12-31 | 239.00K shares 10-K · filed 2019-03-22 | 384.00K shares 10-K · filed 2018-03-09 | ||||||
| 2017-09-30 | 393.00K shares 10-Q · filed 2018-11-09 | |||||||
| 2017-06-30 | 394.00K shares 10-Q · filed 2018-08-06 | |||||||
| 2017-03-31 | 454.00K shares 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | 453.00K shares 10-K · filed 2018-03-09 | |||||||
| 2016-09-30 | 455.00K shares 10-Q · filed 2017-11-08 | |||||||
| 2016-06-30 | 457.00K shares 10-Q · filed 2017-08-04 | |||||||
| 2016-03-31 | 439.00K shares 10-Q · filed 2017-05-04 | 14.32M shares 10-Q · filed 2016-05-09 | ||||||
| 2015-12-31 | 424.00K shares 10-K · filed 2017-03-09 | 13.57M shares 10-K · filed 2016-03-15 | ||||||
| 2015-09-30 | 430.00K shares 10-Q · filed 2016-11-09 | 13.86M shares 10-Q · filed 2015-11-09 | ||||||
| 2015-06-30 | 451.00K shares 10-Q · filed 2016-08-04 | 14.89M shares 10-Q · filed 2015-08-10 | ||||||
| 2015-03-31 | 14.46M shares 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | 13.98M shares 10-K · filed 2016-03-15 | |||||||
| 2014-09-30 | 14.14M shares 10-Q · filed 2015-11-09 | |||||||
| 2014-06-30 | 10.48M shares 10-Q · filed 2015-08-10 | |||||||
| 2014-03-31 | 10.09M shares 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | 9.61M shares 10-K · filed 2015-03-27 | |||||||
| 2013-09-30 | 7.57M shares 10-Q · filed 2013-11-14 | 7.57M shares 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | 7.57M shares 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | 6.92M shares 10-Q · filed 2014-05-15 | |||||||
| 2012-12-31 | 7.03M shares 10-K · filed 2014-03-31 | |||||||
| 2012-09-30 | 6.55M shares 10-Q · filed 2013-11-14 | 7.35M shares 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | 7.68M shares 10-Q · filed 2013-08-14 | |||||||
| 2012-03-31 | 9.01M shares 10-Q · filed 2013-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |